Skip to content

Prospective, Multi-center, Single-arm Study to Assess the Safety of Retrieval of the Recovery G2 Filter.

The Bard® Recovery® Filter Registry (EVEREST) for Patients Who Are Candidates for an Optional (Retrievable) Inferior Vena Cava Filter That Undergo Placement of the Bard® Recovery® Filter.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00556426
Acronym
EVEREST
Enrollment
100
Registered
2007-11-12
Start date
2005-12-31
Completion date
2007-04-30
Last updated
2012-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Embolism, Venous Thromboembolic Disease

Keywords

Venous Thromboembolic Disease, IVC Filter, Pulmonary Embolism

Brief summary

This study was designed to assess the safety of retrieval of the Bard Recovery® G2® Filter System. The G2 filter is an FDA-cleared device for inferior vena caval interruption in patients with pulmonary thromboembolism.

Interventions

DEVICEBard Recovery G2 Filter System

Retrieval of previously placed RECOVERY G2 IVC filter

Sponsors

C. R. Bard
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The patient is at temporary , increased risk of pulmonary embolism requiring caval interruption

Exclusion criteria

* The patient has implanted filter in the IVC or superior vena cava (SVC) * The patient has a duplicated or left-sided IVC * The patient has a known untreatable or uncontrollable malignancy * The patient has severe spinal deformity * The patient has a creatinine \> 2.0 mg/dl * The patient has a life expectancy of \< 6 months

Design outcomes

Primary

MeasureTime frameDescription
Technical Success (Retrieval)1 month post filter retrieval or through 6 months following implantationTechnical success for retrieval of the filter such that the entire filter is removed.
Clinical Success (Retrieval)Time of Retrieval or through 6 months of implantationtechnical success without subsequent damage to the cava wall or other retrieval-related complications requiring intervention.
Percentage of Participants With Adverse Events Through 30 Days Post Retrieval30 days post retrievalAdverse events occurring at the time of retrieval through 30 days post filter retrieval procedure

Secondary

MeasureTime frameDescription
Filter Migration > 2cm30 days post retrieval or 6 months following filter placementPercentage of subjects experiencing filter migrations from the initial placement position of 2cm or more.
Incidence of Filter Fractureat 6 months or at retrieval of the filteroccurrence of fracture assessed at retrieval by the Investigator (broken filter arms, legs, or other components)

Participant flow

Recruitment details

Eleven Investigators at 11 sites enrolled a total of 100 study subjects between December 7, 2005 and July 24, 2006.

Participants by arm

ArmCount
Participants Receiving a Filter
Patients who were at temporary, increased risk of pulmonary embolism requiring inferior vena cava (IVC) interruption, and for whom Recovery G2 Filter retrieval could reasonably be expected to occur within 6 months of device placement.
100
Total100

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyDeath6
Overall StudyWithdrawal by Subject3

Baseline characteristics

CharacteristicParticipants Receiving a Filter
Age Continuous52.1 years
STANDARD_DEVIATION 16.7
Indication for Placement
active thromboembolic disease
43 Number of Participants
Indication for Placement
no active thromboembolic disease
57 Number of Participants
Region of Enrollment
United States
100 participants
Sex: Female, Male
Female
33 Participants
Sex: Female, Male
Male
67 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
70 / 100
serious
Total, serious adverse events
6 / 100

Outcome results

Primary

Clinical Success (Retrieval)

technical success without subsequent damage to the cava wall or other retrieval-related complications requiring intervention.

Time frame: Time of Retrieval or through 6 months of implantation

Population: 61/100 patients experienced filter retrieval during the study

ArmMeasureValue (NUMBER)
All Patients Receiving the FilterClinical Success (Retrieval)57 participants
Primary

Percentage of Participants With Adverse Events Through 30 Days Post Retrieval

Adverse events occurring at the time of retrieval through 30 days post filter retrieval procedure

Time frame: 30 days post retrieval

Population: 61 of 100 patients underwent filter retrieval during the study.

ArmMeasureValue (NUMBER)
All Patients Receiving the FilterPercentage of Participants With Adverse Events Through 30 Days Post Retrieval14.8 percentage of participants
Primary

Technical Success (Retrieval)

Technical success for retrieval of the filter such that the entire filter is removed.

Time frame: 1 month post filter retrieval or through 6 months following implantation

Population: 61 of 100 patients enrolled underwent filter retrieval during the study.

ArmMeasureValue (NUMBER)
All Patients Receiving the FilterTechnical Success (Retrieval)58 participants
Secondary

Filter Migration > 2cm

Percentage of subjects experiencing filter migrations from the initial placement position of 2cm or more.

Time frame: 30 days post retrieval or 6 months following filter placement

Population: Migration measurement made for 58 retrieved subjects, 22 non-retrieved subjects reaching the 6 month visit, and 2 non-retrieved subjects with attempted retrievals and imaging.

ArmMeasureValue (NUMBER)
All Patients Receiving the FilterFilter Migration > 2cm12.2 Percent Subjects with Filter Migration
Secondary

Incidence of Filter Fracture

occurrence of fracture assessed at retrieval by the Investigator (broken filter arms, legs, or other components)

Time frame: at 6 months or at retrieval of the filter

Population: adequate imaging was available to assess filter integrity in 83 of the 100 participants.

ArmMeasureValue (NUMBER)
All Patients Receiving the FilterIncidence of Filter Fracture1 number of fractured filters

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026